Document Detail

Biomarkers in Parkinson's disease: a venture capitalist's perspective.
MedLine Citation:
PMID:  20945985     Owner:  NLM     Status:  In-Process    
The emergence of biomarkers linking disease and treatment effects in a clear manner presents an opportunity to change the current drug development paradigm, which could lead to more cost-efficient and higher-quality clinical trials. This has raised the hopes of venture capital investors, who may be able to better navigate the stormy and risky sea of early-stage life science investments, to find a way out of the current funding crisis for novel, nonvalidated drugs and their clinical development. The following survey paints a snapshot of the current perception of biomarkers as a paradigm changer in the eyes of the venture capital community.
Jens W Eckstein
Related Documents :
23866235 - Relationship between stress symptoms and drug use among secondary students.
20627145 - Research and development of antischistosomal drugs in the people's republic of china a ...
24394215 - Correlates of protective motivation theory (pmt) to adolescents' drug use intention.
25036425 - Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
20399785 - Transporters as mediators of drug resistance in plasmodium falciparum.
6119805 - Mutagenic activation of an antischistosomal drug by enteric streptococcus sps in vitro ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomarkers in medicine     Volume:  4     ISSN:  1752-0371     ISO Abbreviation:  Biomark Med     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312535     Medline TA:  Biomark Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  731-5     Citation Subset:  IM    
TVM Capital, 101 Arch Street, Boston, MA 02030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomarkers in Parkinson's disease: a funder's perspective.
Next Document:  Vascular dysfunction biomarkers are elevated in children with HIV.